Fennec Pharmaceuticals Inc. · NASDAQ:FENC
Southpoint Capital Advisors LP's stake in Fennec Pharmaceuticals Inc. fell below 5% (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 14, 2026
Southpoint Capital Advisors LP's stake in Fennec Pharmaceuticals Inc. fell below 5%, 0 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 0%
- Shares
- 0
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 6 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Southpoint Master Fund, LP | 0% | 0 |
| Southpoint Capital Advisors LP | 0% | 0 |
| Southpoint Capital Advisors LLC | 0% | 0 |
| Southpoint GP, LP | 0% | 0 |
| Southpoint GP, LLC | 0% | 0 |
| John S. Clark II | 0% | 0 |
Source
Related
- Fennec Pharmaceuticals Inc.
- Southpoint Capital Advisors LP
- Fennec Pharmaceuticals Inc. shareholders
- Schedule 13G/A · Southpoint Capital Advisors LP · Jan 14, 2026
- Schedule 13G/A · Orin Hirschman · Oct 19, 2026
- Form 4 · Andrade Robert · Oct 13, 2026
- Form 4 · Cioffi Christiana Marie · Oct 13, 2026
- Form 4 · Evans Terry L · Oct 13, 2026
- Form 4 · Sayad Pierre Sargis · Oct 13, 2026